FDA Approves First Menin Inhibitor for Acute Leukemia
MedPage Today) -- The FDA granted full approval to the menin inhibitor revumenib (Revuforj) for adults and children 1 year...
MedPage Today) -- The FDA granted full approval to the menin inhibitor revumenib (Revuforj) for adults and children 1 year...